The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.
about
The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@ast
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@en
type
label
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@ast
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@en
prefLabel
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@ast
The use of Yttrium-90 Ibritumo ...... ous stem-cell transplantation.
@en
P2093
P2860
P356
P1476
The use of Yttrium-90 Ibritumo ...... gous stem-cell transplantation
@en
P2093
Elżbieta Kisiel
Joanna Sawczuk-Chabin
Omeir Khan
Piotr Centkowski
Wanda Knopińska-Posłuszny
P2860
P356
10.5114/WO.2015.50012
P577
2015-03-26T00:00:00Z